$27.64 1.4%
ARWR Stock Price vs. AI Score (Last 150 days)
Data gathered: July 18

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States.

Arrowhead Pharmaceuticals
Price $27.64
Target Price Sign up
Volume 967,670
Market Cap $3.67B
Year Range $21.2 - $39.48
Dividend Yield 0%
Revenue per Employee $63,106
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24025M-33M-125M-114M-1.020
Q4 '233.6M28M-30M-133M-127M-1.240
Q3 '2311M28M-18M-110M-99M-1.020
Q2 '2311M24M-14M-103M-94M-0.960
Q1 '23141M24M118M49M56M0.450

Insider Transactions View All

Oliver Tracie filed to sell 127,107 shares at $25.3.
July 3 '24
Vakiener Victoria filed to sell 30,205 shares at $23.3.
May 6 '24
Hamilton James C filed to sell 204,851 shares at $28.
April 3 '24
Lu Hongbo filed to buy 33,680 shares at $27.5.
March 20 '24
Myszkowski Kenneth Allen filed to sell 400,600 shares at $35.2.
March 8 '24

What is the Market Cap of Arrowhead Pharmaceuticals?

The Market Cap of Arrowhead Pharmaceuticals is $3.67B.

How Many People Work at Arrowhead Pharmaceuticals?

As of our latest update, Arrowhead Pharmaceuticals employed approximately 397 people worldwide. However, it's important to note that Arrowhead Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Arrowhead Pharmaceuticals' revenue per employee?

$63,106. To calculate Arrowhead Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Arrowhead Pharmaceuticals?

Currently, the price of one share of Arrowhead Pharmaceuticals stock is $27.64.

How can I analyze the ARWR stock price chart for investment decisions?

The ARWR stock price chart above provides a comprehensive visual representation of Arrowhead Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Arrowhead Pharmaceuticals shares. Our platform offers an up-to-date ARWR stock price chart, along with technical data analysis and alternative data insights.

Does ARWR offer dividends to its shareholders?

As of our latest update, Arrowhead Pharmaceuticals (ARWR) does not offer dividends to its shareholders. Investors interested in Arrowhead Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Arrowhead Pharmaceuticals?

Some of the similar stocks of Arrowhead Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.